Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates

por Krege, John H, Gilsenan, Alicia W, Komacko, John L, Kellier‐Steele, Nicole
Publicado 2022

Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15‐Year US Postmarketing Surveillance Study

por Gilsenan, Alicia, Midkiff, Kirk, Harris, David, Kellier‐Steele, Nicole, McSorley, David, Andrews, Elizabeth B
Publicado 2020

Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data

por Gilsenan, Alicia, Midkiff, Kirk, Harris, David, McQuay, Lisa, Hunter, Shannon, Kellier‐Steele, Nicole, Andrews, Elizabeth
Publicado 2020